BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36083855)

  • 1. Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.
    Higurashi T; Ashikari K; Tamura S; Saigusa Y; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Kessoku T; Hosono K; Yoneda M; Nakajima A
    Cancer Prev Res (Phila); 2022 Oct; 15(10):661-668. PubMed ID: 36083855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Aug; 20(1):770. PubMed ID: 32807113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial.
    Higurashi T; Hosono K; Endo H; Takahashi H; Iida H; Uchiyama T; Ezuka A; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Maeda S; Morita S; Natsumeda Y; Nagase H; Nakajima A
    BMC Cancer; 2012 Sep; 12():413. PubMed ID: 22992267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Leukotriene Pathway for Colon Cancer Interception.
    Mohammed A; Shoemaker RH
    Cancer Prev Res (Phila); 2022 Oct; 15(10):637-640. PubMed ID: 36193659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci.
    Kowalczyk M; Sigorski D; Dyśko Ł; Zieliński E; Zupanovich Lucka D; Klepacki Ł
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of RAS inhibitor manumycin A on aberrant crypt foci formation in the azoxymethane-induced rat colorectal carcinogenesis model.
    Tsuda M; Okamoto K; Muguruma N; Sannomiya K; Nakagawa T; Miyamoto H; Kitamura S; Goji T; Kimura T; Okahisa T; Izumi K; Takayama T
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1616-23. PubMed ID: 23730936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
    Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.
    Wali RK; Bianchi L; Kupfer S; De La Cruz M; Jovanovic B; Weber C; Goldberg MJ; Rodriguez LM; Bergan R; Rubin D; Tull MB; Richmond E; Parker B; Khan S; Roy HK
    PLoS One; 2018; 13(4):e0193544. PubMed ID: 29617381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
    Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
    Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
    Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
    Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
    Takayama T; Nagashima H; Maeda M; Nojiri S; Hirayama M; Nakano Y; Takahashi Y; Sato Y; Sekikawa H; Mori M; Sonoda T; Kimura T; Kato J; Niitsu Y
    Clin Cancer Res; 2011 Jun; 17(11):3803-11. PubMed ID: 21385928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.
    Tsai MJ; Wu PH; Sheu CC; Hsu YL; Chang WA; Hung JY; Yang CJ; Yang YH; Kuo PL; Huang MS
    Sci Rep; 2016 Apr; 6():23979. PubMed ID: 27052782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of colonic aberrant crypt foci by Gynura procumbens in rats.
    Shwter AN; Abdullah NA; Alshawsh MA; Alsalahi A; Hajrezaei M; Almaqrami AA; Salem SD; Abdulla MA
    J Ethnopharmacol; 2014 Feb; 151(3):1194-1201. PubMed ID: 24393787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats.
    Mohania D; Kansal VK; Kruzliak P; Kumari A
    Rejuvenation Res; 2014 Aug; 17(4):325-33. PubMed ID: 24524423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.
    Limburg PJ; Mahoney MR; Ziegler KL; Sontag SJ; Schoen RE; Benya R; Lawson MJ; Weinberg DS; Stoffel E; Chiorean M; Heigh R; Levine J; Della'Zanna G; Rodriguez L; Richmond E; Gostout C; Mandrekar SJ; Smyrk TC;
    Cancer Prev Res (Phila); 2011 Feb; 4(2):259-69. PubMed ID: 21209397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.
    Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008202. PubMed ID: 26482324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and diagnosis of aberrant crypt foci.
    Lopez-Ceron M; Pellise M
    Colorectal Dis; 2012 Apr; 14(4):e157-64. PubMed ID: 22182185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of colorectal cancer.
    Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.